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Abstract
The present randomised trial investigated the effects of feeding Zambian infants from 6 to 18 months old either a richly or basal micro-
nutrient-fortified complementary/replacement food on gut integrity and systemic inflammation. Blood samples were obtained from all
infants (n 743) at 6 and 18 months for the assessment of serum C-reactive protein (CRP) and a1-acid glycoprotein (AGP). A subsample
of 502 infants, selected from the main cohort to include a larger proportion of infants with HIV-positive mothers, was assigned to lactu-
lose/mannitol gut permeability tests. Lactulose:mannitol (L:M) ratio analyses were adjusted for baseline urinary L:M ratio, socio-economic
status, mother’s education, season of birth and baseline stunting, and stratified by maternal antenatal HIV status, child’s sex, concurrent
breast-feeding status and anaemia at baseline. There was no significant difference in geometric mean L:M ratio between the richly fortified
and basal-fortified porridge arms at 12 months (0·47 (95 % CI 0·41, 0·55) v. 0·41 (95 % CI 0·34, 0·49); P¼0·16 adjusted). At 18 months, the
richly fortified porridge group had a significantly higher geometric mean L:M ratio than the basal-fortified group (0·23 (95 % CI 0·19, 0·28) v.
0·15 (95 % CI 0·12, 0·19); P¼0·02 adjusted). This effect was evident for all stratifications, significantly among boys (P¼0·04), among the
infants of HIV-negative mothers (P¼0·01), among the infants of HIV-negative mothers not concurrently breast-fed (P¼0·01) and among
those who were not anaemic at baseline (P¼0·03). CRP, but not AGP, was positively associated with L:M ratio, but there were no significant
effects of the diet on either CRP or AGP. In conclusion, a richly fortified complementary/replacement food did not benefit and may have
worsened intestinal permeability.
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Early-life nutrition, especially during the first 2 years, is critical
for human development(1). Growth faltering in infancy esta-
blishes a trajectory for lifelong health of the individual and,
in populations, has profound implications for societal devel-
opment. Growth faltering has special pertinence in regions
undergoing economic and nutrition transition(2,3) such as
urban Zambia, where the ‘double-burden of malnutrition’ is
emergent(4). The prevalence of stunting among children in
Zambia is considered severe at 25 % among 6- to 8-month-
old infants and 59 % among 18- to 23-month-old children
nationally(5). Micronutrient deficiencies are well documented
among infants in Zambia(6–9) and are associated with linear
growth retardation(10).
Stunting and micronutrient deficiencies are not simply
due to inadequate food intake(1). The ‘nutrition–infection
paradigm’(11) and synergism of inadequate diet and infection
in childhood growth faltering are well documented. Mucosal
enteropathy resulting from infection can increase nutrient
loss by maldigestion and malabsorption, and can increase
nutritional requirements through inflammation(12,13). The
intestinal epithelium is the major interface between environ-
mental factors (e.g. diet, pathogens) and systemic health
(e.g. nutritional status, immune responses), and its integrity
is a key, though often neglected, consideration in the
effectiveness of nutrition interventions. Impaired gut per-
meability, as assessed by urinary dual-sugar permeability
tests, has been associated with growth faltering(12–15), mal-
nutrition(12) and parasitic infection(16) in developing
countries. Mucosal barrier damage was associated with sys-
temic acute-phase C-reactive protein (CRP) and lipopoly-
saccharide-binding protein among adult haematology
patients(17), but neither a1-acid glycoprotein (AGP) nor IgG
was associated with gut permeability among Bangladeshi
infants(15).
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Micronutrient supplementation studies, particularly of vita-
min A and Zn, have shown improvements in gut integrity
as assessed by urinary dual-sugar permeability tests. Maternal
vitamin A supplementation prevented the deterioration
of gut integrity of HIV-infected infants in South Africa(18).
McCullough et al.(14) reviewed studies documenting improve-
ments in gut integrity following vitamin A supplementation of
healthy infants in India. Zn supplementation has improved
gut integrity among children with diarrhoeal disease in
Bangladesh(19,20), healthy adults and those with Crohn’s
disease(21,22) and in cell and animal models of gut epithelial
damage(21,23). Fe repletion of anaemic infants and young
children through oral Fe supplementation significantly
reduced gut permeability(24). Elsewhere, Hb concentrations
were negatively associated with mucosal damage among
Nepalese children(13).
The aim of the present study is to investigate the effects of
locally produced complementary/replacement foods, fortified
with micronutrients, on gut integrity, as assessed by urinary
dual-sugar permeability tests, and systemic inflammation, as
assessed by acute-phase protein (APP) concentrations,
among infants aged 6–18 months in the Chilenje Infant
Growth, Nutrition and Infection Study (CIGNIS).
Experimental methods
Subjects and study design
The CIGNIS trial was conducted in Chilenje, a middle-class
suburb of Lusaka, Zambia, between September 2005 and
July 2009. Details of the study protocol, porridge composition
and primary outcomes of the project have been presented
elsewhere(25). Families were recruited through the child
health section of a government clinic on the same site as
the project clinic. Infants were eligible if they were 6
months ^ 2 weeks old, in good health generally and if their
parent/guardian gave written consent to attend monthly
clinic visits for the next year, feed the infant the allocated
project porridge, allow the infant undergo tests including
blood and urine sampling at 6, 12 and 18 months and have
the child tested for HIV at 18 months old. Maternal HIV
status was not tested, but recorded from antenatal charts and
interview as ‘positive’, ‘negative’ or ‘unknown’. Sociodemo-
graphic information was obtained by a questionnaire. Infants
were randomised to either a richly fortified porridge mix to
meet WHO recommendations for infants aged 9–11 months
with low breast milk intakes(26) or a basal porridge mix forti-
fied with micronutrient levels planned for maize fortification
in Zambia(27). The porridges, based on maize, beans, bam-
baranuts and groundnuts, were locally produced by Quality
Commodities Limited, Lusaka, Zambia. Micronutrient pre-
mixes were prepared by DSM, Johannesburg, South Africa.
The Fe fortificant used in both porridges was ferrous fumarate.
Urinary dual-sugar permeability tests
At 6, 12 and 18 months, urinary dual-sugar tests to assess gut
integrity were conducted based on methods described
previously(28,29). All infants of mothers who tested HIV-
positive antenatally or with unknown HIV status and every
second child of mothers who tested HIV-negative antenatally
were assigned to the urinary dual-sugar permeability test.
Children received via a syringe 2 ml/kg body weight of an
oral dose of 200 mg lactulose/ml (C12H22O11; molecular
weight 342·3) and 50 mg mannitol/ml (C6H14O6; molecular
weight 182·2) in sterile water. Urine bags containing cotton
wool were applied and plastic pants worn while urine was
collected for 5 h. Samples were mixed at the clinic before
aliquoting, freezing and storage at 2808C in the University
Teaching Hospital (Lusaka, Zambia). Urine samples were
transported on dry ice to the UK for analysis at the
London School of Hygiene and Tropical Medicine
(LSHTM). Lactulose and mannitol concentrations in urine
samples were measured using enzymatic colorimetric tech-
niques, as described previously(30,31), adapted to a ninety-
six-well plate format (P. Lunn; Human Nutrition Research,
Cambridge, UK). All reagents, unless stated otherwise,
were purchased from Sigma Aldrich (Poole, UK). Lactulose
in standards, samples and quality control (QC) material
was converted through a series of enzymatic reactions cata-
lysed by b-galactosidase, hexokinase, phosphoglucoisome-
rase and glucose-6-phosphate dehydrogenase to glucose-6-
phosphate, with NADPH as a side product. The absorbance
of NADPH, measured at 340 nm, was directly proportionate to
fructose concentration. Lactulose concentrations were deter-
mined by the subtraction of endogenous fructose concen-
trations of samples incubated without b-galactosidase from
those with b-galactosidase. Mannitol in standards, samples
and QC material was converted through enzymatic reactions
catalysed by mannitol dehydrogenase (Biocatalysts, Cardiff,
UK) and hexokinase to fructose-6-phopshate, with NADH as
a side product. The absorbance of NADH, measured at
340 nm, was directly proportionate to mannitol concentration.
The inter-assay CV of the 250 and 1000 mg/l QC material
for the lactulose assay were 10·4 and 5·6 %, respectively.
The inter-assay CV of the 250 and 1000 mg/l QC material for
the mannitol assay were 9·6 and 9·8 %, respectively.
Acute-phase proteins
At 6 and 18 months, 5 ml of blood samples were collected
by venepuncture (Vacutainer 23G butterfly system; Becton
Dickinson, Oxford, UK) for micronutrient and APP analysis.
Samples were centrifuged and serum was divided into
aliquots, and stored at 280oC in the University Teaching
Hospital. Samples for APP analyses were sent on dry ice to
the LSHTM. CRP was measured by ELISA using antibodies
from Abcam (Cambridge, UK) and standards from Dade
Behring (Milton Keynes, UK) according to a protocol detailed
elsewhere(32). The inter-assay CV for the National Institute for
Biological Standards and Control (NIBSC) supplied QC
material was 12·6 %. AGP was analysed on a COBAS FARA
autoanalyser (Roche, Welwyn Garden City, UK) using a com-
mercial immunoturbidometric assay (Kamiya Biomedical,
Seattle, WA, USA). The inter-assay CV for the high and low
QC material were 6·1 and 7·1 %, respectively.
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Statistical analysis
Lactulose:mannitol (L:M) ratios, CRP and AGP concentrations
were transformed on the natural logarithmic scale to normal-
ise distributions of skewed raw data. A value of 1 was
added to all lactulose concentrations so that logs could be cal-
culated even for zero values; since the mean lactulose concen-
tration was 568 mg/l, this would have had a minimal effect on
the geometric mean L:M ratio. Geometric means of the L:M
ratio, CRP and AGP were calculated separately for the inter-
vention arms, and separately at 6, 12 and 18 months. Baseline
characteristics and reported illness within the past 3 d were
compared in those tested and not tested for L:M ratio, CRP
and AGP separately using a x 2 or t test for categorical or con-
tinuous variables, respectively. Transformed L:M ratio, CRP
and AGP were compared between the intervention arms
using a two-sample t test at 12 and 18 months (crude analysis).
Regression coefficients were transformed back to the original
scale to provide a ratio of the geometric means. Baseline L:M
ratio, socio-economic status determined from principal com-
ponent analysis of an asset score(33), season of birth (early
dry: June to August; late dry: September to November; early
rainy: December to February; late rainy: March to May) and
baseline stunting defined as less than 22 SD of length-
for-age using the WHO child growth standards(34) were con-
sidered potential a priori confounders, and adjusted analyses
using multivariable linear regression were performed includ-
ing these variables. Child’s sex, maternal HIV status, concur-
rent breast-feeding status based on maternal HIV status and
anaemia at 6 months were considered a priori to be potential
effect modifiers and stratified analyses were performed for
these variables. Additional non-a priori stratified analysis by
child’s HIV status, tested by PCR at 18 months, was conducted
at 18 months only. Tests of interaction were also performed
between the intervention arm and the potential effect modi-
fiers. A random slope, random intercept mixed-effects linear
regression model was employed to explore the effect of the
intervention on L:M ratio over the entire study period. The
model included a priori confounding factors and covariates
associated with missingness to correct the results for missing
values in the outcome(35). All analyses were conducted in
Stata version 11.0 (College Station, TX, USA).
Sixty-eight inadequately randomised
Not assessed at baseline*
AGP – 16
CRP – 26
L:M – 53
Lost to follow up
L:M – 17
CRP – 37
Lost to follow up
AGP – 96
CRP – 60
L:M – 28
Could not come
for the visit
L:M – 7
811 infants enrolled in the trial
743 randomised
All 743 assigned to AGP/CRP testing
502 assigned to L:M testing
Assessed at 18 months
AGP – 266
CRP – 255
L:M – 164
Basal-fortified porridge
AGP/CRP – 373
L:M – 256
Assessed at 6 months
AGP – 354
CRP – 347
L:M – 209
Assessed at 12 months
L:M – 179
Assessed at 18 months
AGP – 258
CRP – 247
L:M – 148
Assessed at 12 months
L:M – 158
Assessed at 6 months
AGP – 354
CRP – 344
L:M – 193
Richly fortified porridge
AGP/CRP – 370
L:M – 246Not assessed at baseline*
AGP – 19
CRP – 26
L:M – 47 
Lost to follow up
L:M – 21
CRP – 33
Lost to follow up
AGP – 88
CRP – 59
L:M – 24
Could not come
for the visit
L:M – 6 
241 not assigned to L:M
testing according to study
design
Fig. 1. Flow diagram of participants through the Chilenje Infant Growth, Nutrition and Infection Study. * Missing lactulose:mannitol (L:M; urinary dual-sugar per-
meability test) ratio results at baseline are due to the following reasons: mother refused (n 62), unavailability of the L:M dose solution (n 10), infant death between
recruitment and testing (n 1), mother incorrectly reported a negative HIV status (n 4), staff error or insufficient urine (n 23). Missing baseline a1-acid glycoprotein
(AGP) and C-reactive protein (CRP) results are due to the insufficient availability of blood samples.
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Ethical approval and trial registration
This study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the ethics
committees of the University of Zambia and LSHTM. Written
informed consent was obtained from all parents/guardians.
The study is registered as ISRCTN37460449 (www.con-
trolled-trials.com/mrct).
Results
Subject recruitment and characteristics
A total of 811 infants were enrolled in the CIGNIS (Fig. 1).
Of these infants, sixty-eight were inadequately randomised
between May and June 2007 following an inadvertent protocol
violation by clinic staff. Due to temporary unavailability of one
of the porridges at the clinic, infants recruited in this time
period were sequentially provided with the available porridge.
Following detection of this protocol violation, these sixty-eight
children continued on the programme but were removed
from the analysis. Of the adequately randomised infants, 502
were assigned to the urinary dual-sugar permeability test, as
described above. Of these infants, 100 were not assessed
at baseline for reasons including mother’s refusal and a
number of occasions when dual-sugar solution was not avai-
lable in the clinic. The assigned children who did and did
not receive the dual-sugar permeability test were compared
by baseline characteristics and reported illness within the
past 3 d. The children who did not receive the dual-sugar per-
meability test at 6 months were less likely to have HIV-positive
mothers (5·4 v. 44·3 %; P,0·001) and were more likely to
be breast-fed for longer than 6 months (89·0 v. 76·9 %;
P¼0·007); maternal HIV status and breast-feeding duration
were closely linked in this population(36). There was also
weak evidence that mothers of children with missing baseline
data were slightly younger (25·4 (SD 4·8) v. 26·7 (SD 5·9) years;
P¼0·06) and from a higher socio-economic class (P¼0·07).
Table 1. Characteristics of infants and mothers assigned to the urinary dual-sugar permeability test (lactulose:mannitol (L:M)) and acute-phase
protein (APP) analysis
(Mean values, standard deviations, number of subjects and percentages)
Assigned to L:M ratio (n 502) Assigned to APP (n 743)
Basal-fortified
porridge arm (n 256)
Richly fortified
porridge arm (n 246)
Basal-fortified
porridge arm (n 373)
Richly fortified
porridge arm (n 370)
n % n % n % n %
Infants’ characteristics
Female 124 48·4 142 57·7 182 48·8 204 55·1
Birth weight (kg)
Mean 3·1 3·1 3·1 3·1
SD 0·5 0·5 0·5 0·5
Stunted* 34 13·3 27 10·9 51 13·7 40 10·8
Anaemic† 94 36·7 102 41·5 140 37·5 149 40·3
Breast-feeding duration
Never 22 8·6 20 8·1 22 5·9 21 5·7
, 6 months 34 13·3 28 11·4 39 10·5 29 7·8
$ 6 months 200 78·1 198 80·5 312 83·6 320 86·5
Season of birth‡
Early dry 90 35·2 72 29·3 123 33·0 113 30·5
Late dry 59 23·0 61 24·8 83 22·3 93 25·1
Early wet 48 18·8 51 20·7 74 19·8 72 19·5
Late wet 59 23·0 62 25·2 93 24·9 92 24·9
Mothers’ characteristics
Age (years)
Mean 26·4 26·5 26·0 26·4
SD 5·5 5·9 5·7 5·8
Antenatal HIV§ status
Negative 144 56·2 134 54·5 261 70·0 258 69·7
Positive 79 30·9 78 31·7 79 21·2 78 21·1
Unknown 33 12·9 34 13·8 33 8·8 34 9·2
Education
Primary or less 80 31·2 98 39·8 123 33·0 129 34·9
Secondary 112 43·8 78 31·7 157 42·1 127 34·3
College/university 64 25·0 70 28·5 93 24·9 114 30·8
Socio-economic score
Low 84 32·8 87 35·4 127 34·0 123 33·2
Middle 107 41·8 84 34·1 151 40·5 136 36·8
High 65 25·4 75 30·5 95 25·5 111 30·0
* Stunted defined as less than 22 SD of length-for-age using the WHO child growth standards.
† Anaemia defined as ,105 g/l.
‡ Early dry (June to August); late dry (September to November); early rainy (December to February); late rainy (March to May).
§ All infants of HIV-positive mothers and mothers of unknown status and every second child of HIV-negative mothers were assigned to L:M ratio analysis. All infants
enrolled in the Chilenje Infant Growth, Nutrition and Infection Study were assigned to APP analysis.
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There is no suggestion that those with missing data for the L:M
ratio were more likely to be unwell or have poor growth (data
not shown). At baseline, fifty-two and thirty-five infants were
not assessed for CRP and AGP, respectively. These infants
were compared, as above, with those who were tested for
serum APP. Missing CRP data at 6 months were associated
with a smaller proportion of maternally HIV-exposed infants
(11·5 v. 21·9 %; P¼0·04), lower maternal educational achieve-
ment (19·2 v. 35·0 % attaining primary education only; P¼0·03)
and a greater incidence of infant illness in the past 3 d (9·6 v.
3·9 %; P¼0·05). Missing AGP data at 6 months were not associ-
ated with any baseline characteristics. Subject characteristics of
infants and mothers by study arm (Table 1) were similar
except that there appeared to be a slight excess of girls in
the richly fortified porridge group.
Urinary dual-sugar permeability tests
Crude analyses of dual-sugar permeability results at 6, 12 and
18 months are presented in Fig. 2. The geometric mean of the
L:M ratio was similar in both trial arms at both 6 months (basal:
0·39 (95 % CI 0·32, 0·49) v. richly fortified: 0·48 (95 % CI 0·40,
0·58)). At 12 months, there was no difference between the
geometric mean of the L:M ratio in the basal and richly forti-
fied groups (0·41 (95 % CI 0·35, 0·49) v. 0·47 (95 % CI 0·41,
0·55), respectively; P¼0·21 crude analysis). At 18 months,
the geometric mean of the L:M ratio was lower than at
younger ages and was significantly lower in the basal group
(0·15 (95 % CI 0·12, 0·19)) compared with the richly fortified
group (0·23 (95 % CI 0·19, 0·28); P¼0·006 crude analysis).
There was no evidence of the differential effects of the diet
on the L:M ratio at 12 months in adjusted and stratified analysis
(Table 2). There was no statistical evidence of an interaction
between the intervention arm and the a priori potential
effect modifiers of child’s sex (P¼0·77), maternal HIV status
(P¼0·56), current breast-feeding (P¼0·90) and baseline anae-
mia (P¼0·63) at 12 months. After adjustment, the L:M ratio at
18 months remained significantly higher in the richly fortified
arm compared with the basal-fortified arm (adjusted ratio 1·42
(95 % CI 1·06, 1·92); P¼0·02; Table 3). When stratified by
child’s sex, the effect of the intervention on the L:M ratio
was significant among males (adjusted ratio 1·57 (95 % CI
1·02, 2·42); P¼0·04; Table 3). When stratified by maternal
HIV status, there was some suggestion that the effect of the
intervention on the L:M ratio was greater among children of
HIV-negative mothers (adjusted ratio 1·81 (95 % CI 1·15,
2·84); P¼0·01; Table 3). When stratified by breast-feeding
status, not currently breast-feeding infants of HIV-negative
mothers who were given the richly fortified porridge had a
considerably higher L:M ratio than those given the basal
porridge (adjusted ratios 2·28 (95 % CI 1·26, 4·13); P¼0·01;
Table 3). By stratified analysis, there was evidence that infants
who were not anaemic at baseline in the richly fortified arm
had a higher L:M ratio than those in the basal-fortified arm
(adjusted ratio 1·54 (95 % CI 1·05, 2·26); P¼0·03; Table 3).
The effect of the intervention was significant among HIV-
negative children (adjusted ratio 1·40 (95 % CI 1·04, 1·90);
P¼0·03) and was not evident among the ten HIV-positive chil-
dren at 18 months (adjusted ratio 2·40 (95 % CI 0·46, 12·60);
P¼0·30; Table 3). Tests of interaction showed no statistical evi-
dence of an interaction between the intervention arm and the
a priori potential effect modifiers of child’s sex (P¼0·48),
maternal HIV (P¼0·18) and baseline anaemia (P¼0·49) at 18
months. There was no statistical evidence of an interaction
between the intervention arm and child’s HIV status at 18
months (P¼0·53). There was weak evidence to suggest an
interaction between diet and breast-feeding among HIV-nega-
tive mothers (P¼0·09) and breast-feeding among HIV-positive
mothers (P¼0·10). For all subgroups tested at 18 months,
point estimates of L:M ratio values for infants in the richly
fortified study arm were higher than those in the basal arm.
In a random slope, random intercept mixed-effects linear
regression model, after adjusting for visit, a priori confound-
ing factors and characteristics associated with missingness
(breast-feeding duration, mother’s age and HIV status), there
was evidence of an effect of the rich porridge intervention
on the L:M ratio over the whole study period (adjusted ratio
1·11 (95 % CI 1·04, 1·19); P¼0·002).
Acute-phase proteins
At baseline, the geometric means of serum concentrations
of CRP in the basal-fortified (0·52 (95 % CI 0·45, 0·60)) and
richly fortified (0·46 (95 % CI 0·40, 0·54)) groups were similar.
At 6 months of age, 4·1 % of the infants had CRP concentrations
in excess of 5 mg/l. The geometric means of serum AGP con-
centration in the basal-fortified (0·73 (95 % CI 0·69, 0·77)) and
richly fortified (0·72 (95 % CI 0·69, 0·75)) groups were also
similar at baseline. At 6 months of age, 21·1 % of the infants
had AGP concentrations in excess of 1 g/l. At 18 months,
there were no differences in serum CRP concentrations
between the basal-fortified (0·47 (95 % CI 0·39, 0·56)) and
richly fortified (0·54 (95 % CI 0·45, 0·64)) groups. Elevated
CRP concentrations were observed in 3·6 % of the infants.
There were also no differences in serum AGP concentrations
between the basal-fortified (0·74 (95 % CI 0·68, 0·80)) and
richly fortified (0·76 (95 % CI 0·70, 0·83)) groups. At 18
months, 30·5 % of the infants had elevated AGP concentrations.
0·7
0·6
0·5
0·4
0·3
0·2
0·1
0·0
6 12 18
Age (months)
*L
:M
Fig. 2. Lactulose:mannitol (L:M) ratio at 6, 12 and 18 months in the basal-
fortified ( ) and richly fortified ( ) study arms. Values are geometric means
of the L:M ratio, with 95 % CI represented by vertical bars. * Mean values
were significantly different (P¼0·006; crude analysis).
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Table 2. Effects of basal-fortified and richly fortified porridge on lactulose:mannitol (L:M) at 12 months
(Geometric means, number of subjects, ratios and 95 % confidence intervals)
Basal-fortified porridge arm Richly fortified porridge arm
n
Geometric
mean 95 % CI n
Geometric
mean 95 % CI
Crude
ratio* 95 % CI P
Adjusted
ratio*†‡ 95 % CI P
All children 178 0·41 0·35, 0·49 158 0·47 0·41, 0·55 1·16 0·92, 1·45 0·21 1·18 0·93, 1·49 0·16
Sex
Boys 94 0·39 0·30, 0·49 65 0·45 0·36, 0·56 1·16 0·83, 1·63 0·38 1·21 0·86, 1·70 0·28
Girls 84 0·44 0·34, 0·56 93 0·49 0·40, 0·60 1·12 0·82, 1·54 0·47 1·13 0·82, 1·56 0·46
Maternal HIV status§
Negative 85 0·44 0·36, 0·53 67 0·55 0·44, 0·68 1·25 0·89, 1·75 0·20 1·30 0·91, 1·84 0·15
Positive 69 0·35 0·25, 0·49 66 0·39 0·31, 0·50 1·12 0·78, 1·60 0·54 1·13 0·78, 1·63 0·53
Currently breast-feeding among HIV-negative mothers
No 10 0·22 0·13, 0·38 6 0·32 0·25, 0·40 1·44 0·59, 3·53 0·42 1·77 0·71, 4·45 0·22
Yes 74 0·47 0·39, 0·58 61 0·58 0·46, 0·73 1·22 0·90, 1·64 0·20 1·26 0·92, 1·73 0·15
Currently breast-feeding among HIV-positive mothers
No 58 0·30 0·21, 0·43 54 0·36 0·28, 0·47 1·21 0·78, 1·89 0·39 1·27 0·81, 1·99 0·30
Yes 11 0·83 0·43, 1·60 12 0·57 0·33, 0·96 0·68 0·26, 1·81 0·44 0·92 0·33, 2·53 0·87
Anaemia at 6 monthsk
No 117 0·36 0·29, 0·44 89 0·42 0·35, 0·50 1·15 0·86, 1·54 0·33 1·20 0·89, 1·61 0·23
Yes 60 0·52 0·39, 0·70 65 0·55 0·43, 0·71 1·07 0·74, 1·54 0·74 1·07 0·73, 1·56 0·74
* Ratio in geometric means.
† Adjusted for baseline L:M ratio, socio-economic status, mother’s education, season of birth and stunting.
‡ L:M ratio measured among 179 and 158 subjects in the basal-fortified and richly fortified porridge arms, but missing data on stunting for one subject in the basal arm.
§ HIV status not known for twenty-three and nineteen mothers in the basal-fortified and richly fortified treatment arms.
k Anaemia defined as ,105 g/l; data for six subjects were missing.
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Table 3. Effects of basal-fortified and richly fortified porridge on lactulose:mannitol (L:M) at 18 months
(Geometric means, number of subjects, ratios and 95 % confidence intervals)
Basal-fortified porridge arm Richly fortified porridge arm
n*
Geometric
mean 95 % CI n
Geometric
mean 95 % CI
Crude
ratio† 95 % CI P
Adjusted
ratio†‡ 95 % CI P
All children 163 0·15 0·12, 0·19 148 0·23 0·19, 0·28 1·5 1·12, 2·00 0·006 1·42 1·06, 1·92 0·02
Sex
Boys 89 0·14 0·10, 0·19 63 0·23 0·17, 0·32 1·68 1·10, 2·57 0·02 1·57 1·02, 2·42 0·04
Girls 74 0·17 0·13, 0·22 85 0·22 0·17, 0·29 1·32 0·88, 1·98 0·18 1·28 0·84, 1·94 0·25
Maternal HIV status§
Negative 78 0·15 0·10, 0·20 67 0·26 0·19, 0·35 1·78 1·13, 2·73 0·01 1·81 1·15, 2·84 0·01
Positive 62 0·15 0·11, 0·21 61 0·20 0·15, 0·28 1·33 0·82, 2·14 0·25 1·16 0·71, 1·89 0·56
Currently breast-feeding among HIV-negative mothers
No 46 0·10 0·06, 0·15 42 0·20 0·13, 0·29 2·04 1·16, 3·58 0·01 2·28 1·26, 4·13 0·01
Yes 32 0·26 0·16, 0·43 25 0·39 0·25, 0·63 1·51 0·74, 3·05 0·25 1·57 0·76, 3·25 0·22
Currently breast-feeding among HIV-positive mothers
No 56 0·14 0·10, 0·20 55 0·19 0·13, 0·26 1·31 0·81, 2·11 0·27 1·20 0·72, 1·99 0·48
Yes 6 0·30 0·12, 0·76 6 0·45 0·14, 1·41 1·52 0·35, 6·51 0·57 1·03 0·21, 5·12 0·97
Child HIV status
Negative 158 0·15 0·12, 0·18 140 0·22 0·18, 0·26 1·47 1·09, 1·97 0·01 1·40 1·04, 1·90 0·03
Positive 4 0·40 0·10, 1·56 6 0·76 0·18, 3·18 1·90 0·37, 9·75 0·44 2·40 0·46, 12·6 0·30
Anaemia at 6 monthsk
No 104 0·13 0·10, 0·18 83 0·21 0·16, 0·29 1·59 1·09, 2·31 0·02 1·54 1·05, 2·26 0·03
Yes 58 0·19 0·14, 0·27 60 0·26 0·20, 0·33 1·35 0·84, 2·17 0·21 1·24 0·77, 2·02 0·37
* L:M ratio measured among 164 and 148 subjects in the basal-fortified and richly fortified porridge arms, but missing data on stunting for one subject in the basal arm.
† Ratio in geometric means.
‡ Adjusted for baseline L:M ratio, socio-economic status, mother’s education, season of birth and stunting.
§ HIV status not known for twenty-three and nineteen mothers in the basal-fortified and richly fortified treatment arms.
k Anaemia defined as ,105 g/l; data for six subjects were missing.
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The effects of the diet on the proportion of infants with
elevated CRP and AGP concentrations at 18 months were
also analysed by multivariate linear regression, adjusted for
baseline CRP or AGP, respectively, socio-economic status,
season of birth and stunting, and stratified by maternal HIV
status, child’s sex, concurrent breast-feeding, and anaemia at
6 months. There were no significant effects of the diet on
the proportion of infants with elevated CRP or AGP (data
not shown). CRP concentrations were correlated with AGP
(r 0·32; P,0·001) and L:M ratio (r 0·13; P¼0·02) at 18
months. There was no evidence of an association between
AGP and L:M ratio at 18 months.
Discussion
The present study investigated the effects of two locally pro-
duced complementary/replacement foods, basal-fortified and
richly fortified with micronutrients, on gut integrity and sys-
temic inflammation among Zambian infants at 6 and 18
months. Presented elsewhere, the richly fortified porridge
improved Fe status at 18 months assessed by Hb, ferritin
and serum transferrin receptors but had no significant effect
overall on the proportion of infants stunted, rate of hospital
referral or death(25). Future work will explore associations
between gut integrity and other outcomes of the trial, includ-
ing anthropometric indices and diarrhoeal disease.
In the present study, intestinal permeability was signifi-
cantly higher at 18 months in the richly fortified porridge
arm compared with the basal-fortified porridge arm, albeit
an 11 % increase. This effect remained after adjustment for
baseline L:M ratio, socio-economic status, mother’s education,
season of birth and stunting. There was no statistical evidence
that the effect of the intervention was modified by child’s sex,
maternal HIV status, concurrent breast-feeding and baseline
anaemia, although there was some suggestion that the effect
of the intervention was greater among children of HIV-
negative mothers who were breast-feeding at 18 months. It
is possible that, in the CIGNIS cohort, mothers of children
with illness associated with higher gut permeability chose to
breast-fed for longer. Among Nepalese children weaned
relatively late, a positive association between duration of
breast-feeding and the L:M ratio has been found(37). There
were no differences in hospital referrals for diarrhoea between
the treatment groups(25) nor in clinic-treated diarrhoea or
monthly maternal reports of diarrhoeal symptoms (A Mullen,
N Larke and S Filteau, unpublished results) despite the
increased intestinal permeability of children in the richly forti-
fied arm. Furthermore, although raised intestinal permeability
is sometimes associated with poor child growth, the richly for-
tified porridge did not impair the growth of CIGNIS children.
There were no significant differences in APP concentrations
between the porridge arms at 18 months.
Impaired intestinal permeability in infants in developing
countries is associated with enteropathy, infection and
growth faltering(12,15,16,38,39). No cut-off for a ‘normal’ L:M
ratio has been recognised. Intestinal permeability as inter-
preted by the L:M ratio in the CIGNIS cohort decreased over
time and values were relatively similar to those published
from the Gambia (children aged 2–16 months; geometric
means at 2-monthly intervals range from 0·17 to approxi-
mately 0·4)(39), Peru (children ,36 months with rotaviral,
cryptosporidial infects and healthy controls; geometric
means of 0·67, 0·76 and 0·29, respectively)(16) and Bangladesh
(children aged 3–15 months; geometric mean of 0·15)(15).
Intestinal integrity in infants has been improved through sup-
plementation with vitamin A(14,18) and Zn(19,20). Fe-deficiency
anaemia may be associated with impaired intestinal integ-
rity(13,24), although evidence suggests a complex interaction
of Fe status with gut permeability, potentially mediated
through innate immune responses and oxidative stress. A
two-by-two factorial intervention of Fe and multi-micronutri-
ent supplements among schoolchildren in Lusaka found that
Fe supplementation significantly increased the L:M ratio com-
pared with the control group, and that Fe supplementation
was the only predictor among the variables tested (including
anthropometric indices, multi-micronutrient supplementation,
parasitic infection and geophagy) of the L:M ratio(40). Review
of Fe supplementation or fortification of milks or cereals
demonstrated that, though not of public health concern, pro-
vision of Fe was associated with an increased risk of diar-
rhoea(41) and gastrointestinal infections(42) among children,
especially among those Fe-replete at baseline. A previous
study in Sprague–Dawley rats has indicated that an Fe-suffi-
cient diet resulted in a significantly higher L:M ratio than an
Fe-deficient diet(43). Fe overload of rats by subcutaneous injec-
tion, though inducing no change in gut permeability, induced
significant morphological changes including a decrease in
crypt depths and tissue Fe content, including the small- and
large-intestinal walls(44). In vitro membrane damage and cellu-
lar death of Caco-2 cells(45) and oxidative DNA damage of
HT29 colon carcinoma cells(46) following Fe exposure has
been demonstrated. Latunde-Dada(47) reviewed ‘hemunology’
and the dynamic between the host’s tightly regulated mechan-
isms of Fe absorption, strategies to deprive pathogens of Fe
and the host’s less-well-developed adaptations to rid the
body of excess Fe. Unabsorbed, or unharnessed, dietary Fe
may thus favour enteric pathogen growth(48). Zimmermann
et al.(48) demonstrated increased enterobacteria and faecal cal-
protectin, a marker of gut inflammation, following a 6-month
intervention with a poorly absorbed Fe fortificant among chil-
dren in Coˆte d’Ivoire. It would seem plausible in the present
study that a higher L:M ratio observed in the richly fortified
porridge arm at 18 months compared with the basal-fortified
porridge arm may be associated with Fe status which was
improved in the richly fortified porridge group(25), particularly
since the effect was significant among infants who were not
anaemic, interpreted by Hb concentration, at baseline. This
has been supported by non-a priori unpublished findings
investigating the effects of the diet on gut permeability of
CIGNIS children at 18 months stratified by baseline transferrin
receptor and ferritin status. Although the biological signi-
ficance of the 11 % increase in gut permeability from
the richly fortified group is questionable, further research is
warranted into understanding the potential effects of Fe
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fortification on gut permeability in infants and children with
normal indices of Fe status.
Gut permeability has been associated with systemic inflam-
mation in a limited number of studies. Campbell et al.(39)
found that plasma endotoxin and IgG-endotoxin core anti-
body were related to mucosal enteropathy among Gambian
infants. AGP and IgG were not associated with gut per-
meability among Bangladeshi infants(15). Faecal neopterin, a
marker of intestinal infection, was not associated with gut
permeability in Gambian infants(38). In the present study,
AGP and CRP concentrations correlated with each other, but
only CRP was associated with the L:M ratio at 18 months.
The richly fortified diet had no effect on APP. If gut per-
meability mediates systemic inflammation, the present finding
would cast further question on the biological significance of
the main finding of the study. However, since the present
and other studies have demonstrated a limited association
between chosen systemic mediators of inflammation and gut
permeability, it is likely that the effect of the diet on gut
permeability is a local effect.
Understanding the ‘nutrition–infection paradigm’(11) should
be a key component in evaluating the success of any nutrition
intervention. The small intestine represents the frontier of
absorption and innate immunology. The CIGNIS investigated
the effects of micronutrients on the function of the small
intestine among infants in Zambia, a population vulnerable
to growth restriction. The results of the CIGNIS, and other
studies, warrant further investigation into local interactions
of key micronutrients with gut integrity, particularly in micro-
nutrient-replete infants.
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